ClinicalTrials.Veeva

Menu

Antiplatelet Use in Dementia Subtypes

G

Gulhane Training and Research Hospital

Status

Completed

Conditions

Dementia Disorder
Dementia

Study type

Observational

Funder types

Other

Identifiers

NCT07313137
GTRH-ANTIPL-DEM-01

Details and patient eligibility

About

This population-based retrospective cohort study aimed to evaluate the appropriateness of antiplatelet therapy use among older adults with all-cause dementia and across different dementia subtypes. Medical records of patients aged 65 years and older who were evaluated at a tertiary-level geriatric outpatient clinic were reviewed. Dementia subtypes were classified according to internationally accepted diagnostic criteria. Patterns of antiplatelet use were assessed in accordance with current guideline recommendations. The study sought to determine the appropriateness of antiplatelet use across dementia subtypes and to describe real-world prescribing practices in this population.

Enrollment

683 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 65 years and older.
  • Diagnosis of dementia based on internationally accepted diagnostic criteria.
  • Evaluation at a tertiary-level geriatric outpatient clinic.

Exclusion criteria

  • Patients with incomplete or inaccessible medical records.
  • Individuals with missing data on antiplatelet therapy use.

Trial design

683 participants in 1 patient group

Dementia cohort
Description:
This cohort includes older adults aged 65 years and older diagnosed with dementia who were evaluated in a tertiary geriatric outpatient clinic. No intervention was assigned, as this is a retrospective observational study.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems